Tumors related to the eye, also known as ocular tumors or eye cancer, can range from harmless to potentially life-threatening and can be primary (first discovered in the eye) or metastatic (spreading from another location).
Our team is focused on treating all types of childhood tumors and cancers affecting the eye. Retinoblastoma is the most common type of intraocular cancer found in children. We also diagnose and treat a wide range of other cancers in the eye, such as gliomas, astrocytomas, lymphomas, and rhabdomyosarcomas.
We also treat non-cancerous tumors that affect the eye (called hamartomas).
Our expertise in ocular oncology
Led by Efren Gonzalez, MD, and Junne Kamihara, MD, PhD, the Ocular Oncology Center brings together a multidisciplinary team of experts from:
- ocular oncology
- pediatric oncology
- pediatric ophthalmology
- neuro-interventional radiology
- cancer genetics
- vitreoretinal surgery
- social work
Together, we provide exceptional, coordinated care to patients diagnosed with ocular oncology conditions. This permits us to not only treat the oncologic aspect of the disease but also provide care for the complete assessment and rehabilitation of the eye, allowing for proper development of the visual system.
Why choose the Ocular Oncology Center
The Ocular Oncology Center represents the combined expertise of the Department of Ophthalmology at Boston Children’s Hospital and the Department of Pediatric Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. We are one of just a handful of pediatric programs in the world with a program dedicated entirely to eye problems caused by neoplastic conditions. Our team relies on a multidisciplinary approach to patient care and works closely to coordinate efforts with the specialized services listed above. This allows families to access all aspects of their child’s care one place — without the need for additional travel.
Through our strong collaboration with Dana-Farber Cancer Institute, families also have access to our robust research program, including clinical trials in which children can receive the newest treatments. A major focus of our program is the rapid translation of scientific discoveries to the bedside to benefit patients. Through this research, our physicians work to improve therapeutic approaches and outcomes for children with ocular tumors.